Warburton Capital Management, LLC

Position in LLY — ELI LILLY & Co

CIK 2054795 TULSA, OK

Position in LLY

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$566,131

+$164,192 QoQ

Shares Held

472

+8.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.64%

of 13F equity value

Holder Rank

#3,656

of 4,605 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Warburton Capital Management, LLC holds $1,474,189 across 5 Drug Manufacturers - General names. LLY ranks #1 (38.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	472	$566,131
2	JNJ	Johnson & Johnson	1,006	$255,493
3	ABBV	AbbVie Inc.	897	$225,721
4	GILD	Gilead Sciences, Inc.	1,740	$219,831
5	MRK	Merck & Co., Inc.	1,611	$207,013

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$566,131	472	+8.0%	Shares	Sole	2026-08-03
2026-03-31	$401,939	437	+9.5%	Shares	Sole	2026-05-01
2025-12-31	$428,797	399	+43.0%	Shares	Sole	2026-01-23
2025-09-30	$212,877	279	-9.7%	Shares	Sole	2025-10-10
2025-06-30	$240,874	309	+26.6%	Shares	Sole	2025-07-31
2025-03-31	$201,522	244	—	Shares	Sole	2025-05-09
No filing history on record for this holder in this stock.